Skip to main content
SpringerLink
Log in

Effects on the Uterus

  • Chapter
Ergot Alkaloids and Related Compounds

Abstract

“The obstetrician bids, and the uterus contracts” was the title of Chassar Moir’s Sandoz Foundation lecture given in 1964 (Moir, 1964). With this categorical statement he pointed to the great reliability of some drugs, and in particular of ergot, in causing the uterus to contract, thereby diminishing or preventing postpartum haemorrhage and reducing maternal mortality in childbirth.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Similar content being viewed by others

References

  • Adair, F.L., Haugen, J.A.: A study of suspended human uterine muscle strips in vitro. Amer. J. Obstet. Gynec. 37, 753–762 (1939)

    CAS  Google Scholar 

  • Adair, F.L., Davis, M.E.: A study of human uterine motility. Amer. J. Obstet. Gynec. 27, 383–394 (1934)

    Google Scholar 

  • Adair, F.L., Davis, M.E., Kharasch, M.S., Legault, R.R.: A study of a new potent ergot derivative, ergotocin. Amer. J. Obstet. Gynec. 30, 466–480 (1935)

    Google Scholar 

  • Altman, S.G., Waltman, R., Lubin, S., Reynolds, S.R.M.: Oxytocic and toxic actions of dihydroergotamine-45. Amer. J. Obstet. Gynec. 64, 101–109 (1952)

    PubMed  CAS  Google Scholar 

  • Alvarez, H.: Discussion: motility of parts of human uterus. In: Oxytocin. Caldeyro-Barcia, R., Heller, H. (eds.), pp. 309–311. Oxford: Pergamon Press 1961

    Google Scholar 

  • Alvarez, H., Caldeyro, R.: Contractility of the human uterus recorded by new methods. Surg. Gynec. Obstet. 91, 1–13 (1950)

    PubMed  CAS  Google Scholar 

  • Alvarez, H., Mendez-Bauer, C., Sica Blanco, Y.: Actión de la hydergina sobre la contractilidad del utero húmano grávido. An. Ginecotocol. 2, 67–72 (1954–55)

    Google Scholar 

  • Bachbauer, A.: Über die Wirkung eines halbsynthetischen Sekalealkaloids als Wehenmittel auf tokometrischer Grundlage. Geburtsh. u. Frauenheilk. 6, 278–289 (1944)

    Google Scholar 

  • Barger, G.: The alcaloids of ergot. In: Handbuch der experimentellen Pharmakologie, Vol. VI, Heubner, W., Schuller, J. (eds.), pp. 130–134, 177–179, 185–190. Berlin-Heidelberg-New York: Springer 1938

    Google Scholar 

  • Baskin, M.J., Crealock, F.W.: The management of cervical spasm with dihydroergotamine methanesulfonate (DHE-45). West. J. Surg. 58, 302–307 (1950)

    PubMed  CAS  Google Scholar 

  • Baumgarten, K.: Die Uterusmotilität beim weiblichen Zyklus. Geburtsh. u. Frauenheilk. 30, 921–933 (1970)

    CAS  Google Scholar 

  • Baumgarten, K., Fröhlich, H., Seidl, A., Sokol, K., Lim-Rachmat, F., Hager, R.: A new β-sympathomimetic preparation for intravenous and oral inhibition of uterine contractions. Europ. J. Obstet. Gynec. 1, 69–83 (1971)

    Article  Google Scholar 

  • Berde, B.: Discussion: motility of parts of human uterus. In: Oxytocin. Caldeyro-Barcia, R., Heller, H. (eds.), p. 309. Oxford: Pergamon Press 1961

    Google Scholar 

  • Berde, B., Cerletti, A.: Quantitative comparison of substances related to oxytocin: a new test. Acta endocr. (Kbh.) 27, 314–324 (1958)

    CAS  Google Scholar 

  • Berde, B., Rothlin, E.: Über die Uteruswirkung hydrierter Mutterkornalkaloide an Kaninchen und Katzen vor, während und nach der Geburt. Helv. physiol. pharmacol. Acta 11, 274–282 (1953)

    PubMed  CAS  Google Scholar 

  • Berde, B., Saameli, K.: Evaluation of substances acting on the uterus. In: Methods in Drug Evaluation. Mantegazza, P., Piccinini, F. (eds.), pp. 481–514. Amsterdam: North-Holland Publishing Company 1966

    Google Scholar 

  • Berde, B., Stürmer, E.: The biological assay of oxytocin in the presence of ergometrine. J. Pharm. Pharmacol. 14, 169–171 (1962)

    Article  PubMed  CAS  Google Scholar 

  • Bosch, K.: Über die Entwicklung, Technik und Resultate der kontinuierlichen Amniondruckmessung und ihrer Kombination mit simultaner externer Tokographie sub partu. Schweiz. med. Wschr. 84, 850–855 (1954)

    PubMed  CAS  Google Scholar 

  • Bourne, A., Burn, J.H.: The dosage and action of pituitary extract and of the ergot alkaloids on the uterus in labour, with a note on the action of adrenalin. J. Obstet. Gynaec. Brit. Emp. 34, 249–268 (1927)

    Article  Google Scholar 

  • Bourne, A.W., Burn, J.H.: Oxytocin and vasopressin on the uterus in labour. Lancet 1928 II, 694–695

    Article  Google Scholar 

  • Bourne, A.W., Burn, J.H.: Action on the human uterus of anaesthetics and other drugs commonly used in labour. Brit. med. J. 2, 87–89 (1930)

    Article  PubMed  CAS  Google Scholar 

  • Broom, A.W., Clark, A.J.: The standardisation of ergot preparations. J. Pharmacol. exp. Ther. 22, 59–74 (1923)

    CAS  Google Scholar 

  • Brown, G.L., Dale, H.: The pharmacology of ergometrine. Proc. roy. Soc. B118, 446–477 (1935)

    Google Scholar 

  • Brügger, I.: Experimenteller Beitrag zur Wirkungsweise vegetativer Pharmaka. Arch. int. Pharmacodyn. 59, 43–60 (1938)

    Google Scholar 

  • Bruns, P.D., Snow, R.H., Drose, V.E.: Effect of dihydroergotamine on human uterine contractility. Obstet. and Gynec. 1, 188–196 (1953)

    CAS  Google Scholar 

  • Carballo, M.A., Caldeyro Barcia, R., Alvarez, H., Agüero, O., Mendy, J.C.: Accion de la metilergonovina sobre la contractilidad uterina durante el alumbramiento. Bol. Soc. chil. Obstet. Ginec. 18, 252–263 (1953)

    PubMed  CAS  Google Scholar 

  • Cibils, L.A., Hendricks, C.H.: Effect of ergot derivatives and sparteine sulfate upon the human uterus. J. Reprod. Med. 2, 147–167 (1969)

    Google Scholar 

  • Clegg, P.C.: The effect of adrenergic blocking agents on the guinea-pig uterus in vitro, and a study of the histology of the intrinsic myometrial nerves. J. Physiol. (Lond.) 169, 73–90 (1963)

    CAS  Google Scholar 

  • Coutinho, E.M.: Tubal and uterine motility. In: Proceedings of the 15th Nobel Symposium 1970, Sweden. Diczfalusy, E., Borell, U. (eds.), pp. 97–115. New York-London-Sydney: Wiley 1971

    Google Scholar 

  • Coutinho, E.M., Maia, H., Nascimento, L.: The response of the human Fallopian tube to ergonovine and methyl-ergonovine in vivo. Amer. J. Obstet. Gynec. 126, 48–54 (1976)

    PubMed  CAS  Google Scholar 

  • Daels, J.: Uterine contractility patterns of the outer and inner zones of the myometrium. Obstet. and Gynec. 44, 315–326 (1974)

    CAS  Google Scholar 

  • Dale, H.H.: The new ergot alkaloid. Science 82, 99–101 (1935)

    Article  PubMed  CAS  Google Scholar 

  • Dale, H.H., Spiro, K.: Die wirksamen Alkaloide des Mutterkorns. Naunyn-Schmiedebergs Arch. exp. Path. Pharmak. 95, 337–350 (1922)

    Article  CAS  Google Scholar 

  • Davis, M.E., Adair, F.L., Rogers, G., Kharasch, M.S., Legault, R.R.: A new active principle in ergot and its effects on uterine motility. Amer. J. Obstet. Gynec. 29, 155–167 (1935a)

    CAS  Google Scholar 

  • Davis, M.E., Adair, F.L., Chen, K.K., Swanson, E.E.: The pharmacologic action of ergotoxin, a new ergot principle. J. Pharmacol. exp. Ther. 54, 398–407 (1935b)

    CAS  Google Scholar 

  • Davis, M.E., Adair, F.L., Pearl, S.: The present status of oxytocics in obstetrics. J. Amer. med. Ass. 107, 261–267 (1936)

    Article  Google Scholar 

  • De Boer, J., Van Dongen, K.: Experiments with dihydroergotamine. Arch. int. Pharmacodyn. 77, 434–441 (1948)

    Google Scholar 

  • Deis, R.P., Pickford, M.: The effect of autonomic blocking agents on uterine contractions of the rat and the guinea-pig. J. Physiol. (Lond.) 173, 215–225 (1964)

    CAS  Google Scholar 

  • De Koning Gans, H.J., Martinez, A.A.V., Eskes, T.K.A.B.: Intermittent low-dose administration of prostaglandins intra-amniotically in pathological pregnancies. Europ. J. Obstet. Gynec. Reprod. Biol. 5/6, 307–315 (1975)

    Article  Google Scholar 

  • Dudley, H.W., Moir, C.: The substance responsible for the traditional clinical effect of ergot. Brit. med. J. 1, 520–523 (1935)

    Article  PubMed  CAS  Google Scholar 

  • Embrey, M.P.: Simultaneous intramuscular injection of oxytocin and ergometrine: a tocography study. Brit. med. J. 1, 1737–1738 (1961)

    Article  Google Scholar 

  • Embrey, M.P., Garrett, W.J.: A study of the effects of dihydroergotamine on the intact human uterus. J. Obstet. Gynaec. Brit. Emp. 62, 150–154 (1955)

    Article  PubMed  CAS  Google Scholar 

  • Embrey, M.P., Garrett, W.J.: Ergometrine with hyaluronidase: speed of action. Brit. med. J. 2, 138–139 (1958)

    Article  PubMed  CAS  Google Scholar 

  • Eschbach, W., Hanke, R.: Uterusmotilität post abortum. Zbl. Gynäk. 75, 481–489 (1953)

    CAS  Google Scholar 

  • Fanchamps, A., Doepfner, W., Weidmann, H., Cerletti, A.: Pharmakologische Charakterisierung von Deseril®, einem Serotonin-Antagonisten. Schweiz. med. Wschr. 90, 1040–1046 (1960)

    PubMed  CAS  Google Scholar 

  • Fegerl, H., Narik, G.: Die Beeinflussung der Wehentätigkeit durch das sympathische und parasympathische Nervensystem. Geburtsh. u. Frauenheilk. 11, 822–834 (1951)

    CAS  Google Scholar 

  • Flury, F.: Pharmakologische Untersuchungen am ausgeschnittenen menschlichen Uterus. Z. Geburtsh. Gynäk. 87, 291–300 (1924)

    Google Scholar 

  • Foster, G.E., Stewart, G.A.: The stability of ergometrine preparations, chemical and biological studies. Quart. J. Pharmacol. 21, 211–218 (1948)

    CAS  Google Scholar 

  • Fraser, A.M.: The effect of magnesium on the response of the uterus to posterior pituitary hormones. J. Pharmacol. exp. Ther. 66, 85–94 (1939)

    CAS  Google Scholar 

  • Fregnan, G.B., Glässer, A.H.: Activity of eledoisin, other polypeptides and ergometrine on the uterus in situ of rabbit and other animal species. J. Pharm. Pharmacol. 16, 744–750 (1964)

    Article  PubMed  CAS  Google Scholar 

  • Fröhlich, H.: Steuermechanismen der Motilitat des nichtgraviden Uterus in situ. Wien. klin. Wschr. 86 (Suppl. 24), 3–28 (1974)

    Google Scholar 

  • Fuchs, A.-R., Fuchs, F.: The effect of oxytocic substances upon the rabbit uterus in situ. Acta physiol. scand. 49, 103–113 (1960)

    Article  PubMed  CAS  Google Scholar 

  • Garg, K.N., Sharma, S., Bala, S.: Experimental studies of sparteine sulphate on strips of human uterus. Jap. J. Pharmacol. 23, 195–200 (1973)

    Article  PubMed  CAS  Google Scholar 

  • Garrett, W.J.: The effects of adrenaline, noradrenaline and dihydroergotamine on excised human myometrium. Brit. J. Pharmacol. 10, 39–44 (1955)

    PubMed  CAS  Google Scholar 

  • Garrett, W.J.: A theory of uterine action. J. Obstet. Gynaec. Brit. Emp. 66, 927–938 (1959)

    Article  PubMed  CAS  Google Scholar 

  • Garrett, W.J.: Why ergometrine? A review of ergot in practice today. Med. J. Aust. 47/1, 677–680 (1960)

    Google Scholar 

  • Garrett, W.J., Embrey, M.P.: The effect of the hydrogenated ergotoxine-group alkaloids on the intact human uterus. J. Obstet. Gynaec. Brit. Emp. 62, 523–529 (1955)

    Article  PubMed  CAS  Google Scholar 

  • Garrett, W.J., Moir, J.C.: Ergot and the non-pregnant uterus. J. Obstet. Gynaec. Brit. Emp. 65, 583–587 (1958)

    Article  PubMed  CAS  Google Scholar 

  • Gill, R.C.: The effect of methyl-ergometrine on the human puerperal uterus. J. Obstet. Gynaec. Brit. Emp. 54, 482–488 (1947)

    Article  PubMed  CAS  Google Scholar 

  • Gill, R.C.: Further observations on the effect of dihydroergotamine upon human uterine action. J. Obstet. Gynaec. Brit. Emp. 60, 103–109 (1953)

    Article  PubMed  CAS  Google Scholar 

  • Gill, R.C., Farrar, J.M.: Experiences with di-hydro-ergotamine in the treatment of primary uterine inertia. J. Obstet. Gynaec. Brit. Emp. 58, 79–91 (1951)

    Article  PubMed  CAS  Google Scholar 

  • Härtfelder, G., Kuschinsky, G., Mosler, H.K.: Über pharmakologische Wirkungen an elektrisch gereizten glatten Muskeln. Naunyn-Schmiedebergs Arch. exp. Path. Pharmak. 234, 66–78 (1953)

    Article  Google Scholar 

  • Hendricks, C.H., Brenner, W.E.: Cardiovascular effects of oxytocic drugs used post partum. Amer. J. Obstet. Gynec. 108, 751–760 (1970)

    PubMed  CAS  Google Scholar 

  • Hendricks, C.H., Reid, D.W.J., Van Fraagh, I., Cibils, L.A.: Effect of sparteine sulfate upon uterine activity in human pregnancy. Amer. J. Obstet. Gynec. 91, 1–9 (1965)

    PubMed  CAS  Google Scholar 

  • Hool-Zulauf, B., Stürmer, E.: Oxytocic activity of two dihydro-ergot peptide alkaloids on the rabbit uterus in situ. Abstr. of the 17th Spring Meeting, March 23–26, 1976, Mainz. Naunyn-Schmiedebergs Arch. Pharmacol. 293 (Suppl.), 139 (1976)

    Article  Google Scholar 

  • Hool-Zulauf, B., Stürmer, E.: Oxytocic activity of two dihydrogenated ergot peptide alkaloids on the rabbit uterus in situ. Arzneimittel-Forsch. 27, 2323–2325 (1977)

    CAS  Google Scholar 

  • Huber, R.: Tokographische Kontrolle einiger gebrauchlicher Sekale-Rein-Alkaloide am menschlichen Uterus post partum. Zbl. Gynak. 78, 748–756 (1956)

    CAS  Google Scholar 

  • Ingelman-Sundberg, A., Lindgren, L., Ryden, G., Sandberg, F.: The spontaneous motility of uterine fibromyomata and their responses to pharmacological stimuli. Acta obstet. gynec. scand. 36, 263–269 (1957)

    Article  PubMed  CAS  Google Scholar 

  • Ivy, A.C., Hartman, C.G., Koff, A.: The contractions of the monkey uterus at term. Amer. J. Obstet. Gynec. 22, 388–399 (1931)

    Google Scholar 

  • Jeffcoate, T.N.A., Wilson, J.K.: The effect of hydergine on uterine action. Lancet 1955 I, 1187–1190

    Article  Google Scholar 

  • Jelinek, E.: Resultate der oralen Anwendung von Hydergin während der 1. Geburtsphase. Gynaecologia (Basel) 143, 414–425 (1957)

    CAS  Google Scholar 

  • Kharasch, M.S., King, H., Stoll, A., Thompson, M.R.: The new ergot alkaloid. Science 83, 206–207 (1936)

    Article  PubMed  CAS  Google Scholar 

  • Kimbell, N.: Intramuscular ergometrine and hyaluronidase in prevention of post-partum haemorrhage. Brit. med. J. 2, 130–131 (1954)

    Article  PubMed  CAS  Google Scholar 

  • Kirchhof, A.C., Racely, C.A., Wilson, W.M., David, N.A.: An ergonovine-like oxytocic synthetized from lysergic acid. West. J. Surg. 52, 197–208 (1944)

    CAS  Google Scholar 

  • Koff, A.K.: A study of the action of ergot on the human puerperal uterus. Surg. Gynec. Obstet. 60, 190–202 (1935)

    Google Scholar 

  • Konzett, H.: Specific antagonism of dibenamine to ergometrine. In: Ciba Foundation Symposium on Adrenergic Mechanism. Wolstenholme, G.E.W., O’Connor, M. (eds.), pp. 463–465. London: Churchill 1960

    Google Scholar 

  • Kremer, H., Narik, G.: Die pharmakodynamische Beeinflußbarkeit der Uterusmotorik sub partu. Geburtsh. u. Frauenheilk. 15, 433–443 (1955)

    CAS  Google Scholar 

  • Mayer, M., Halpern, B., Nogueira, I.: Accouchement — Délivrance; étude pharmacodynamique de certaines substances utéro-sédatives et utéro-contracturantes. Bull. Féd. Soc. Gynéc. Obstét. franč. 7, 591–604 (1955)

    Google Scholar 

  • Miller, G.B., De Beer, E.J.: The ability of ergotoxine to modify the contractile action of ergonovine on the isolated uterus. J. Pharmacol. exp. Ther. 104, 412–415 (1952)

    PubMed  CAS  Google Scholar 

  • Moir, C.: Clinical comparison of ergotoxine and ergotamine. Brit. med. J. 1, 1022–1024 (1932a)

    Article  PubMed  CAS  Google Scholar 

  • Moir, C.: The action of ergot preparations on the puerperal uterus. Brit. med. J. 1, 1119–1122 (1932b)

    Article  PubMed  CAS  Google Scholar 

  • Moir, C.: The effect of posterior lobe pituitary gland fractions on the intact human uterus. J. Obstet. Gynaec. Brit. Emp. 51, 181–197 (1944)

    Article  Google Scholar 

  • Moir, C., Russel, C.S.: An investigation of the effect of ergot alkaloids in promoting involution of the postpartum uterus. J. Obstet. Gynaec. Brit. Emp. 50, 94–104 (1943)

    Article  Google Scholar 

  • Moir, J.C.: The obstetrician bids, and the uterus contracts. Brit. med. J. 2, 1025–1029 (1964)

    Article  PubMed  CAS  Google Scholar 

  • Müller, H.A., Ströker, W.: Studien über die Uterusmotilität. Die spontane Motilität in der Postplacentarperiode und Methergin wirkung. Arch. Gynäk. 191, 369–376 (1959)

    Article  Google Scholar 

  • Myerscough, P.R., Schild, H.O.: Quantitative assays of oxytocic drugs on the human postpartum uterus. Brit. J. Pharmacol. 13, 207–212 (1958)

    PubMed  CAS  Google Scholar 

  • Nelson, E.E., Calvery, H.O.: Present status of the ergot question. Physiol. Rev. 18, 297–327 (1938)

    CAS  Google Scholar 

  • Oettel, H., Bachmann, H.: Untersuchungen am puerperalen Säugeruterus über Hypophysin, Ergometrin und Mutterkornextrakte. Naunyn-Schmiedebergs Arch. exp. Path. Pharmak. 185, 242–258 (1937)

    Article  CAS  Google Scholar 

  • Orth, O.S.: Studies of the sympathicolytic drug dihydroergotamine (D.H.E. 45). Fed. Proc. 5, 196 (1946)

    Google Scholar 

  • Orth, O.S., Ritchie, G.: A pharmacological evaluation of dihydroergotamine methanesulfonate (D.H.E. 45). J. Pharmacol. exp. Ther. 90, 166–173 (1947)

    PubMed  CAS  Google Scholar 

  • Pennefather, J.N.: The estimation of ergometrine on the rat uterus. J. Pharm. Pharmacol. 13, 60–61 (1961)

    Article  PubMed  CAS  Google Scholar 

  • Pereira Martinez, A., Del Sol, J.R., Slocker, Castro, C.: Los alcaloides dihydrogenados del cornezuelo de centeno en obstetricia. Acta ginec. (Madr.) 1, 7–18 (1954)

    Google Scholar 

  • Reist, A.: Neuere Auffassungen über Wesen und Behandlung von geburtsstörenden Anomalien des Weichteilweges. In: Schweizerisches Medizinisches Jahrbuch, pp. XLI–LVII. Basel: Schwabe 1949

    Google Scholar 

  • Reynolds, S.R.M., Harris, J.S., Kaiser, I.H.: Effects of adrenalin and noradrenalin on uterine contractions. In: Clinical Measurements of Uterine Forces in Pregnancy and Labor, p. 221. Springfield Ill.: Thomas 1954

    Google Scholar 

  • Robson, J.M.: The reactivity and activity of the human uterus at various stages of pregnancy and at parturition. J. Physiol. (Lond.) 79, 83–93 (1933)

    CAS  Google Scholar 

  • Roth-Brandel, U., Bygdeman, M., Wiqvist, N.: A comparative study on the influence of prostaglandin Et, oxytocin and ergometrin on the pregnant human uterus. Acta obstet. gynec. scand. 49 (Suppl. 5), 1–7 (1970)

    Article  Google Scholar 

  • Rothlin, E.: Über die pharmakologische und therapeutische Wirkung des Ergotamins auf den Sympathicus. Klin. Wschr. 30, 1437–1443 (1925)

    Article  Google Scholar 

  • Rothlin, E.: Sur les propriétés pharmacologiques d’un nouvel alcaloïde de l’ergot de seigle, l’ergobasine. C.R. Soc. Biol. (Paris) 119, 1302–1311 (1935a)

    CAS  Google Scholar 

  • Rothlin, E.: Über ein neues Mutterkornalkaloid. Schweiz. med. Wschr. 65, 947–949 (1935b)

    Google Scholar 

  • Rothlin, E.: Beitrag zur differenzierenden Analyse der Mutterkornalkaloide. Schweiz. med. Wschr. 68, 971–975 (1938a)

    CAS  Google Scholar 

  • Rothlin, E.: Chemisch-pharmakologische Stellungnahme zum Mutterkornproblem. Arch. Gynäk. 166, 88–105 (1938b)

    Article  Google Scholar 

  • Rothlin, E.: Zur Pharmakologie der hydrierten naturlichen Mutterkornalkaloide. Helv. physiol. Pharmacol. Acta 2, C48–C49 (1944)

    CAS  Google Scholar 

  • Rothlin, E.: Zur Pharmakologie des Sympathicolyticums Dihydroergotamin DHE 45. Schweiz. med. Wschr. 76, 1254–1259 (1946)

    PubMed  CAS  Google Scholar 

  • Rothlin, E.: The pharmacology of the natural and dihydrogenated alkaloids of ergot. Bull. schweiz. Akad. med. Wiss. 2, 249–273 (1946/47)

    Google Scholar 

  • Rothlin, E.: Pharmacology of lysergic acid diethylamide and some of its related compounds. J. Pharm. Pharmacol. 9, 569–587 (1957)

    Article  PubMed  CAS  Google Scholar 

  • Rothlin, E., Berde, B.: Über die Wirkung hydrierter Mutterkornalkaloide auf isolierte Muskelstreifen des menschlichen Uterus nahe am Termin, am Termin und während der Geburt. Helv. physiol. pharmacol. Acta 12, 191–205 (1954)

    PubMed  CAS  Google Scholar 

  • Rothlin, E., Brügger, J.: Quantitative Untersuchungen der sympathikolytischen Wirkung genuiner Mutterkornalkaloide und derer Dihydroderivate am isolierten Uterus des Kaninchens. Helv. physiol. pharmacol. Acta 3, 519–535 (1945)

    CAS  Google Scholar 

  • Rudzik, A.D., Miller, J.W.: The mechanism of uterine inhibitory action of relaxin-containing ovarian extracts. J. Pharmacol. exp. Ther. 138, 82–87 (1962)

    PubMed  CAS  Google Scholar 

  • Sandberg, F., Ingelman-Sundberg, A., Lindgren, L., Ryden, G.: Comparison of in vitro and in vivo effects of four synthetic oxytocics on pregnant human uterus. Arzneimittel-Forsch. 9, 544–548 (1959)

    CAS  Google Scholar 

  • Sandberg, F., Ingelman-Sundberg, A., Lindgren, L., Ryden, G.: The effect of oxytocin on the motility of different parts of the pregnant and non-pregnant human uterus in vitro as compared with other oxytocic drugs. In: Oxytocin. Caldeyro-Barcia, R., Heller, H. (eds.), pp. 295–312. Oxford: Pergamon Press 1961

    Google Scholar 

  • Sauter, H.: Verwendung von Dihydroergotamin (DHE 45) in der Geburtshilfe. Schweiz. med. Wschr. 78, 475–480 (1948)

    PubMed  CAS  Google Scholar 

  • Sauter, H.: Gefäßwirkung verschiedener Pharmaka, insbesondere von Adrenalin und der dihydrierten Secalealkaloide beim postpartalen menschlichen Uterus. Schweiz. med. Wschr. 79, 572–576 (1949a)

    PubMed  CAS  Google Scholar 

  • Sauter, H.: Die konstriktorische Wirkung verschiedener Wehenmittel auf die Uterusgefäße. Gynaecologia (Basel) 127, 302–324 (1949b)

    CAS  Google Scholar 

  • Sauter, H.: Beziehungen zwischen Uterustonus und Uterusdurchblutung. Schweiz. med. Wschr. 80, 1306–1309 (1950)

    Google Scholar 

  • Schild, H.O.: The use of incomplete randomized blocks in an oxytocic assay. In: Quantitative Methods in Human Pharmacology and Therapeutics: Proceedings of a Symposium Held in London, March, 1958. Laurence, D.R. (ed.), pp. 154–159. London: Pergamon Press 1959

    Google Scholar 

  • Schild, H.O., Fitzpatrick, R.J., Nixon, W.C.W.: Activity of the human cervic and corpus uteri. Lancet 1951 I, 250–253

    Article  Google Scholar 

  • Shaaban, A.H., Youssef, A.F.: Effect of autonomic drugs on uterine action in labour. Gaz. Egypt. Soc. Gynaec. Obstet. 9, 107–132 (1959)

    Google Scholar 

  • Slaytor, M., Pennefather, J.N., Wright, S.E.: Metabolites of LSD and ergometrine. Experientia (Basel) 15, 111 (1959)

    Article  CAS  Google Scholar 

  • Smith, R.G.: The present status of ergonovine. J. Amer. med. Ass. 111, 2201–2209 (1938)

    Article  CAS  Google Scholar 

  • Smyth, C.N.: A comparison of the effects of oxytocin and ergometrine on the human uterus. In: Oxytocin. Caldeyro-Barcia, R., Heller, H. (eds.), pp. 281–294. Oxford: Pergamon Press 1961

    Google Scholar 

  • Snow, R.H., Bruns, P.D., Drose, V.E.: Effect of hydergine (dihydrogenated ergot) on preeclampsia and uterine contractility. Amer. J. Obstet. Gynec. 70, 302–307 (1955)

    PubMed  CAS  Google Scholar 

  • Stoll, A., Burckhardt, E.: L’ergobasine, un nouvel alcaloïde de l’ergot de seigle, soluble dans l’eau. C.R. Acad. Sci. (Paris) 200, 1680–1682 (1935)

    CAS  Google Scholar 

  • Stolte, L.A.M., Eskes, T.K.A.B., Seelen, J.C.: Uterine activity and adrenaline derivatives. Acta physiol. pharmacol. need. 12, 179–180 (1963)

    Google Scholar 

  • Stürmer, E., Flückiger, E.: In vivo smooth muscle stimulant activity of 2-bromo-α-ergokryptine mesylate (CB 154) as compared with that of ergotamine. IRCS med. Sci. 2, 1591 (1974)

    Google Scholar 

  • Sund, R.B.: On the actions of ergometrine on isolated rat uterus in absence and presence of magnesium ions. Medd. norske farm. Selsk. 25, 89–96 (1963a)

    CAS  Google Scholar 

  • Sund, R.B.: Assay of oxytocin in pharmaceutical solutions containing both oxytocin and ergometrine, by the isolated rat uterus method. Medd. norske farm. Selsk. 25, 101–114 (1963b)

    CAS  Google Scholar 

  • Swanson, E.E., Hargreaves, C.C.: The action of ergot and its alkaloids on the puerperal uteri of dogs. J. Amer. pharm. Ass. sci. Ed. 23, 867–872 (1934)

    Article  CAS  Google Scholar 

  • Thompson, M.R.: Some properties of ergostetrine. J. Amer. pharm. Ass. 24, 748–753 (1935)

    Article  CAS  Google Scholar 

  • Tothill, A.: Investigation of adrenaline reversal in the rat uterus by the induction of resistance to isoprenaline. Brit. J. Pharmacol. 29, 291–301 (1967)

    PubMed  CAS  Google Scholar 

  • Tuck, V.L.: A clinical test of the newly recognized oxytocic principle of ergot and a new method of administration. Amer. J. Obstet. Gynecol. 5, 718–723 (1935)

    Google Scholar 

  • Venkatasubbu, V.S., Gopala Krishnamurthy, L.B.: Pharmacological and clinical evaluation of the action of hydrogenated ergot alkaloids on the uterus. Curr. Med. Pract. 3, 629–638 (1959)

    Google Scholar 

  • Vos, Jr., B.J.: Use of the latent period in the assay of ergonovine on the isolated rabbit uterus. J. Amer. pharm. Ass. sci. Ed. 32, 138–141 (1943)

    Article  CAS  Google Scholar 

  • Votava, Z., Podvalova, I.: Pharmacological studies of ergometrine and methylergometrine. Acta pharmacol. (Kbh.) 13, 309–318 (1957)

    Article  CAS  Google Scholar 

  • Wellhöner, H.-H.: Wirkung von Pharmaka auf die glatte Muskulatur der Scheide. Naunyn-Schmiedebergs Arch. exp. Path. Pharmak. 236, 167 (1959a)

    Article  Google Scholar 

  • Wellhöner, H.-H.: Antagonistische Beeinflussung der Methylergobasinwirkung an Uterus und Vagina durch einige Sympathicolytika und Adrenolytika. Med. exp. (Basel) 1, 138–145 (1959b)

    Article  Google Scholar 

  • Wilhelm, F.: Verwendungsmöglichkeiten des Hydergin in der Geburtshilfe. Klin. Med. (Wien) 6, 414–421 (1951)

    CAS  Google Scholar 

  • Wiqvist, N.: Desensitizing effect of exo-and endogenous relaxin on the immediate uterine response to relaxin. Acta endocr. (Kbh.) 46 (Suppl.), 3–14 (1959)

    Google Scholar 

Download references

Authors
  1. K. Saameli
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Forschung und Entwicklung, Pharmazeutisches Departement, Sandoz AG, 4002, Basel, Schweiz

    B. Berde

  2. University College London, London WC1, Great Britain

    H. O. Schild (Emeritus Professor of Pharmacology in the University of London) (Emeritus Professor of Pharmacology in the University of London)

Rights and permissions

Reprints and permissions

Copyright information

© 1978 Springer-Verlag Berlin · Heidelberg

About this chapter

Cite this chapter

Saameli, K. (1978). Effects on the Uterus. In: Berde, B., Schild, H.O. (eds) Ergot Alkaloids and Related Compounds. Handbook of Experimental Pharmacology / Handbuch der experimentellen Pharmakologie, vol 49. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-66775-6_4

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-66775-6_4

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-66777-0

  • Online ISBN: 978-3-642-66775-6

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation